Human interindividual variability in susceptibility to airborne particles

Risk Analysis

Volumn 21, Issue 4, 2001, Pages 585-599

  Hattis, Dale ^a   Russ, Abel ^a   Goble, Robert ^a   Banati, Prerna ^a   Chu, Margaret ^b  

^a CLARK UNIVERSITY   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Interindividual variability; Particles; Pharmacodynamics; Pharmacokinetics

Indexed keywords

OZONE; PHARMACOKINETICS; POPULATION STATISTICS;

AIRBORNE PARTICLES;

EPIDEMIOLOGY;

ALLERGEN; METHACHOLINE; OZONE; SODIUM METABISULFITE;

AIR QUALITY; HEALTH RISK; PARTICULATE MATTER; POLLUTION EXPOSURE;

AIRBORNE PARTICLE; ARTICLE; BREATHING RATE; DISEASE PREDISPOSITION; DUST; ENVIRONMENTAL EXPOSURE; FLOUR; FORCED EXPIRATORY VOLUME; LUNG FUNCTION;

AIR POLLUTANTS; DISEASE SUSCEPTIBILITY; HUMANS; RESPIRATORY PHYSIOLOGY; VARIATION (GENETICS);

EID: 0035703460     PISSN: 02724332     EISSN: None     Source Type: Journal    
DOI: 10.1111/0272-4332.214137     Document Type: Article

References (59)

1. The association of mortality and particulate air pollution
2. Air pollution, weather, and mortality in Philadelphia 1973-1988
3. Mortality and air pollution: Associations persist with continued advances in research methodology
4. Health effects of particulate air pollution: Time for reassessment?
5. Air pollution and daily mortality. A review and meta-analysis
6. Increased mortality in Philadelphia associated with daily air pollution concentrations
7. Air pollution and daily mortality: Associations with particulates and acid aerosols
8. Long-term inhalable particles and other air pollutants related to mortality in nonsmokers
9. An association between air pollution and mortality in six U.S. cities
10. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults
11. Is daily mortality associated specifically with fine particles?
12. Human interindividual variability in parameters related to health risks
13. Distributions of individual susceptibility among humans for toxic effects - For what fraction of which kinds of chemicals and effects does the traditional 10-fold factor provide how much protection?
14. Metabolically consistent breathing rates for use in dose assessments
15. Developing univariate distributions from data for risk analysis
16. Assessment of variability and uncertainty distributions for practical risk analyses
17. The effect of particle size on the regional deposition of inhaled aerosols in the human respiratory tract
18. Deposition efficiency of monodisperse particles in human respiratory tract
19. Regional deposition of 2.5 to 5.0 μm polystyrene microspheres inhaled by women
20. Regional deposition of inhaled particles in human lungs: Comparison between men and women
21. Effect of exercise on deposition and subsequent retention of inhaled particles
22. The effect of bronchial obstruction on central airway deposition of a saline aerosol in patients with asthma
23. Patterns of distribution and clearance of aerosols in patients with bronchiectasis
24. Mucociliary clearance in patients with chronic bronchitis and bronchial carcinoma
25. Deposition of fine particles in children spontaneously breathing at rest
26. Effect of allergen challenge on airway responsiveness to histamine and sodium metabisulphite in mild asthma
27. Distribution of bronchial responsiveness in a general population: Effect of sex, age, smoking, and level of pulmonary function
28. Dose response analysis using spreadsheets
29. Cumulative and reversible effects of lifetime smoking and simple tests of lung function in adults
30. Quantitative relationships between cigarette smoking and ventilatory function
31. Association of fine particulate matter from different sources with daily mortality in six U.S. cities
32. Long term health effects of particulate and other ambient air pollution: Research can progress faster if we want it to
33. Respiratory tract deposition of ultrafine particles in subjects with obstructive or restrictive lung disease
34. Biological variability of particle deposition in the human respiratory tract during controlled and spontaneous mouth-breathing
35. An indication on the biological variability of aerosol total deposition in humans
36. Human variation in the peripheral airspace deposition of inhaled particles
37. Particle deposition in the respiratory tract of children during spontaneous and controlled breathing
38. Airway inflammation and responsiveness to ozone in normal and asthmatic subjects
39. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease
40. Prevalence of bronchial reactivity to inhaled methacholine in New Zealand children
41. Bronchial responsiveness in a Norwegian community
42. Effect of exposure to low levels of ozone on the response to inhaled allergen in allergic asthmatic patients
43. Analysis of dose-response curves to methacholine: An approach suitable for population studies
44. Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid
45. Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population
46. The relationship of nonspecific bronchial responsiveness to respiratory symptoms in a random population sample
47. Simple tests of respiratory function and study of sensory response in human subjects exposed to respiratory tract irritants
48. Quantitative bronchial challenge tests with wheat flour dust administered by spinhaler: Comparison with aqueous wheat flour extract inhalation
49. Proportion of moderately exercising individuals responding to low-level, multi-hour ozone exposure
50. Strategies for assessing human variability in susceptibility, and using variability to infer human risks
51. 2-agonists in the management of asthma